Skip to content

Controllability of cognitive brain signals and the effects on the frontostriatal network: A 7T fMRI study.

Controllability of cognitive brain signals and the effects on the frontostriatal network: A 7T fMRI study. - Controllability of cognitive brain signals

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON40199
Enrollment
30
Registered
2013-06-11
Start date
2014-05-20
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The research is fundamental in nature and only healthy subjects are studied. The knowledge that will be gained could eventually be used for medical interventions (e.g. new treatment methods for psychiatric disorders). Furthermore, the results are interesting for those who are developing brain-computer interfaces. NA

Interventions

Subjects will be included for a real time feedback study in an fMRI setup. Subjects will train to gain control over the brain activity of the DLPFC. The effects of training on the activation of the

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Right-handed - Age 18-45

Exclusion criteria

Exclusion criteria: - History of psychiatric illness - Pregnancy - Metal objects in or around the body (braces, pacemaker, metal fragments) - Claustrophobia

Design outcomes

Primary

MeasureTime frame
The main study parameter is the change in BOLD activation patterns of the frontostriatal system after training to self-regulate brain activity of the DLPFC (comparing the post and pre-training count-back network activation task).

Secondary

MeasureTime frame
The secondary study parameters are the feedback performance and brain activation patterns during the feedback task with distracters, relative to that without distracters.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)